Neratinib in Combination With Ruxolitinib in Patients With mTNBC

Clinical trial NCT06008275 · RECRUITING

Trial details

NCT number: NCT06008275
Sponsor: Baylor Research Institute
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Metastatic Triple-Negative Breast Carcinoma Breast Cancer

Start date: 2024-09-16
Primary completion: 2026-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.